openPR Logo
Press release

Global Pharmaceutical Products Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc.

05-19-2017 09:34 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Pharmaceutical Products Market Research Reports,

The published titles of Pharmaceutical Products Market reports by iHealthcareAnalyst, Inc. include Abumin, Active Pharmaceutical Ingredients, Acute Ischemic Stroke Diagnosis and Treatment, Anti-Aging Products and Services, Antibacterial Drugs, Anxiety Disorders and Depression Treatment, Bacterial Conjunctivitis Drugs, Breast Cancer Therapeutics, Cancer Immunotherapy, Chemotherapy-Induced Nausea and Vomiting Drugs, Chromatography Accessories and Consumables, Chromatography Systems, Collagen Peptide, Contraceptive Drugs and Devices, Diabetes Drugs and Devices, Dilated Cardiomyopathy Therapeutics, Drug Device Combination Products, Dyslipidemia Drugs, Epigenetics Drugs, Erectile Dysfunction Drugs, Exocrine Pancreatic Insufficiency Diagnostics, Fragment-Based Drug Discovery, Gelatin, Geriatric Medicines, Glaucoma Therapeutics, Glioblastoma Multiforme Drugs, Hemophilia Treatment, Heparin Anticoagulant, Highly Potent Active Pharmaceutical Ingredients, Hospital Pharmaceutical Drugs, Hospital-Acquired Infection Therapeutics, Hospital-Acquired Pneumonia Drugs, Hyaluronic Acid Injections, Hypertrophic Cardiomyopathy Therapeutics, Inhalation and Nasal Spray Generic Drugs, Kidney Cancer Drugs, Liver Diseases Therapeutic Drugs, Menopausal Hot Flashes Therapy, Mouth Ulcers Drugs, Multiple Sclerosis Treatment, Nanomedicine, Nonalcoholic Steatohepatitis Treatment, Non-Small Cell Lung Cancer Therapeutics, Opioid Induced Constipation Drugs, Oral Contraceptive Pills, Organ Preservation Solutions, Organ Transplant Immunosuppressant Drugs, Osteoporosis Drugs, Pain Management Therapeutic Drugs, Parenteral Nutrition, Peptide Therapeutics, Periodontal Disease Therapeutics, Pharmacovigilance, Primary Immunodeficiency Diseases, Psoriasis Treatment, Pulmonary Arterial Hypertension, Pulmonary Drugs, Radiopharmaceuticals, Short Bowel Syndrome Diagnostics and Treatment, Smoking Cessation and Nicotine De-Addiction Products, Spinal Muscular Atrophy Treatment, Thyroid Gland Disorders Treatment, Ultraviolet Germicidal Irradiation, and Veterinary Antiseptic Drugs.

The global pharmaceutical products market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Browse Global Pharmaceutical Products Market Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/pharmaceuticals/

Table of Contents
1. Introduction
2. Executive Summary
2.1. Market Size Estimation (Revenue USD Million, 2014-2021)
2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
3. Research Methodology
4. Market Landscape
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Barriers
4.1.3. Opportunities
4.2. Market Share Analysis
4.2.1. Companies
4.2.2. Drugs
4.3. Market Trends Analysis
4.3.1. Key success factors
4.3.2. Market Growth Rate
4.4. Market Attractiveness Analysis
4.5. Market Profitability Analysis
4.5.1. Buyer power
4.5.2. Supplier power
4.5.3. Barriers to entry
4.5.4. Threat of substitute products
4.5.5. Rivalry among firms in the industry
4.6. Distribution Channels
5. Market Segmentation
5.1. Drug Class or Drug (Brand) Type
5.2. Drug or Disorder Test
5.3. Indication Type
5.4. Drug Treatment
5.5. Mechanism of Action
5.6. Therapeutic Area or Nature of Application
5.7. End User Groups
6. Geography (Region, Country)
6.1. North America (U.S., Canada)
6.2. Latin America (Brazil, Mexico, Rest of LA)
6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
6.4. Asia Pacific (Japan, China, India, Rest of APAC)
6.5. Rest of the World
7. Regulatory Overview
7.1. IND, NDA filed, FDA, EMEA Approvals
8. Pipeline Analysis (Phase 1, 2 and 3 Drugs)
8.1. Phase 3 Drugs Forecast Estimation (Approval to 2025)
8.2. Phase 1 and 2 Drugs – Qualitative Analysis
9. Company Profiles
9.1. Company Overview
9.2. Financial Snapshot (FY 2014-2016)
9.3. Product Portfolio
9.4. Business Strategies
9.5. Recent Developments
10. Recommendations
11. References

To request Table of Contents and Sample Pages of these reports visit:
https://www.ihealthcareanalyst.com/reports/pharmaceuticals/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmaceutical Products Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. here

News-ID: 542836 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase